All Stories

  1. Relationships of GDAP1 Mutations to Disease Phenotype and Mechanisms of Therapeutic Action of Oxidative Metabolism Activators in a Patient with Charcot–Marie–Tooth Neuropathy Type 2K
  2. Thiamine, gastrointestinal beriberi and acetylcholine signaling
  3. Supramolecular Protein Assemblies: Building Blocks, Organism- or Cell-Specific Varieties, and Significance
  4. Combined Administration of Metformin and Amprolium to Rats Affects Metabolism of Free Amino Acids in the Brain, Altering Behavior, and Heart Rate
  5. A challenging interplay between basic research, technologies and medical education to provide therapies based on disease mechanisms
  6. Pharmacological Doses of Thiamine Benefit Patients with the Charcot–Marie–Tooth Neuropathy by Changing Thiamine Diphosphate Levels and Affecting Regulation of Thiamine-Dependent Enzymes
  7. Posttranslational Acylations of the Rat Brain Transketolase Discriminate the Enzyme Responses to Inhibitors of ThDP-Dependent Enzymes or Thiamine Transport
  8. Posttranslational Acylations of the Rat Brain Transketolase Discriminate the Enzyme Responses to Inhibitors of ThDP-Dependent Enzymes or Thiamine Transport
  9. Pentylenetetrazole-Induced Seizures Are Increased after Kindling, Exhibiting Vitamin-Responsive Correlations to the Post-Seizures Behavior, Amino Acids Metabolism and Key Metabolic Regulators in the Rat Brain
  10. The Therapeutic Potential of Vitamins B1, B3 and B6 in Charcot–Marie–Tooth Disease with the Compromised Status of Vitamin-Dependent Processes
  11. Therapeutic Potential of Vitamins in Charcot-Marie-Tooth Disease with the Compromised Status of the Vitamin-Dependent Processes
  12. Inhibition of pyruvate dehydrogenase affects the brain protein acylation stronger than PDHA phosphorylation at Ser293
  13. Phosphonate Inhibitors of Pyruvate Dehydrogenase Perturb Homeostasis of Amino Acids and Protein Succinylation in the Brain
  14. The Brain Protein Acylation System Responds to Seizures in the Rat Model of PTZ-Induced Epilepsy
  15. Phosphonate Inhibitors of Pyruvate Dehydrogenase Perturb Homeostasis of Amino Acids and Protein Succinylation in the Brain
  16. Structural Basis for the Binding of Allosteric Activators Leucine and ADP to Mammalian Glutamate Dehydrogenase
  17. Structural Basis for the Binding of Allosteric Activators Leucine and ADP to Mammalian Glutamate Dehydrogenase
  18. Acute Prenatal Hypoxia in Rats Affects Physiology and Brain Metabolism in the Offspring, Dependent on Sex and Gestational Age
  19. Regulation of p53 Function by Formation of Non-Nuclear Heterologous Protein Complexes
  20. Increasing Inhibition of the Rat Brain 2-Oxoglutarate Dehydrogenase Decreases Glutathione Redox State, Elevating Anxiety and Perturbing Stress Adaptation
  21. Thiamine‐dependent regulation of mammalian brain pyridoxal kinase in vitro and in vivo
  22. Characterization of Novel Pathogenic Variants Causing Pyridox(am)ine 5′-Phosphate Oxidase-Dependent Epilepsy
  23. Preparation of Affinity Purified Antibodies against ε-Glutaryl-Lysine Residues in Proteins for Investigation of Glutarylated Proteins in Animal Tissues
  24. Physiological and Biochemical Markers of the Sex-Specific Sensitivity to Epileptogenic Factors, Delayed Consequences of Seizures and Their Response to Vitamins B1 and B6 in a Rat Model
  25. Daytime Dependence of the Activity of the Rat Brain Pyruvate Dehydrogenase Corresponds to the Mitochondrial Sirtuin 3 Level and Acetylation of Brain Proteins, All Regulated by Thiamine Administration Decreasing Phosphorylation of PDHA Ser293
  26. Physiological and Biochemical Markers of the Gender-specific Sensitivity to Epileptogenic Factors, Delayed Consequences of Seizures and Their Response to Vitamins B1 and B6 in a Rat Model of Epilepsy
  27. Positive correlation between rat brain glutamate concentrations and mitochondrial 2-oxoglutarate dehydrogenase activity
  28. Quantification of Rat Brain Amino Acids: Analysis of the Data Consistency
  29. Inhibition of mitochondrial 2-oxoglutarate dehydrogenase impairs viability of cancer cells in a cell-specific metabolism-dependent manner
  30. Production of superoxide/hydrogen peroxide by the mitochondrial 2-oxoadipate dehydrogenase complex
  31. Mitochondrial Impairment May Increase Cellular NAD(P)H: Resazurin Oxidoreductase Activity, Perturbing the NAD(P)H-Based Viability Assays
  32. Molecular mechanisms of the non-coenzyme action of thiamin in brain: biochemical, structural and pathway analysis
  33. The RNA-binding protein HuR is essential for the B cell antibody response
  34. P.1.g.080 The activity of brain 2-oxoglutarate dehydrogenase complex in non-pregnant and pregnant rats before and after hypoxic exposure
  35. The 2-Oxoacid Dehydrogenase Complexes in Mitochondria Can Produce Superoxide/Hydrogen Peroxide at Much Higher Rates Than Complex I
  36. Benefits of Thiamin (Vitamin B1) Administration in Neurodegenerative Diseases may be Due to Both the Coenzyme and Non-coenzyme Roles of Thiamin
  37. Thiamin-dependent enzymes: new perspectives from the interface between chemistry and biology
  38. Thiamin diphosphate-dependent enzymes: from enzymology to metabolic regulation, drug design and disease models
  39. Translating Enzymology into Metabolic Regulation: The Case of the 2- Oxoglutarate Dehydrogenase Multienzyme Complex
  40. Up-regulation of 2-oxoglutarate dehydrogenase as a stress response
  41. Ketoglutarate dehydrogenase in neurodegeneration
  42. On the role of the mitochondrial 2-oxoglutarate dehydrogenase complex in amino acid metabolism
  43. Phosphonate Analogs of 2-Oxoglutarate Perturb Metabolism and Gene Expression in Illuminated Arabidopsis Leaves
  44. Chronic alcoholism in rats induces a compensatory response, preserving brain thiamine diphosphate, but the brain 2-oxo acid dehydrogenases are inactivated despite unchanged coenzyme levels
  45. Metabolic Networking through Enzymatic Sensing, Signaling and Response to Homeostatic Fluctuations
  46. A Survey of Oxidative Paracatalytic Reactions Catalyzed by Enzymes that Generate Carbanionic Intermediates: Implications for ROS Production, Cancer Etiology, and Neurodegenerative Diseases
  47. Tricarboxylic Acid Cycle Activity Regulates Tomato Root Growth via Effects on Secondary Cell Wall Production
  48. Behavioral Impact of the Regulation of the Brain 2-Oxoglutarate Dehydrogenase Complex by Synthetic Phosphonate Analog of 2-Oxoglutarate: Implications into the Role of the Complex in Neurodegenerative Diseases
  49. Role of 2-oxoglutarate dehydrogenase in brain pathologies involving glutamate neurotoxicity
  50. Metabolic control exerted by the 2-oxoglutarate dehydrogenase reaction: a cross-kingdom comparison of the crossroad between energy production and nitrogen assimilation
  51. Regulation of Catalysis Within Cellular Network: Metabolic and Signaling Implications of the 2-Oxoglutarate Oxidative Decarboxylation
  52. Regulation of Catalysis Within Cellular Network: Metabolic and Signaling Implications of the 2-Oxoglutarate Oxidative Decarboxylation
  53. Phosphono Analogues of 2-Oxoglutarate Protect Cerebellar Granule Neurons upon Glutamate Excitotoxicity
  54. Succinyl phosphonate, a protector of the 2-oxoglutarate dehydrogenase complex, corrects behavioral impairments in rats exposed to hypoxia or ethanol
  55. Synthetic regulators of the 2-oxoglutarate oxidative decarboxylation alleviate the glutamate excitotoxicity in cerebellar granule neurons
  56. α-Ketoglutarate dehydrogenase contributes to production of reactive oxygen species in glutamate-stimulated hippocampal neurons in situ
  57. Interaction of thioredoxins with target proteins: Role of particular structural elements and electrostatic properties of thioredoxins in their interplay with 2-oxoacid dehydrogenase complexes
  58. Inhibition of 2-Oxoglutarate Dehydrogenase in Potato Tuber Suggests the Enzyme Is Limiting for Respiration and Confirms Its Importance in Nitrogen Assimilation
  59. Novel isoenzyme of 2-oxoglutarate dehydrogenase is identified in brain, but not in heart
  60. P.1.d.011 Phosphonate analogue of ketoglutarate increases activity of ketoglutarate dehydrogenasecomplex in situ and in vivo
  61. Structure-function relationships in the 2-oxo acid dehydrogenase family: Substrate-specific signatures and functional predictions for the 2-oxoglutarate dehydrogenase-like proteins
  62. Enzyme-Catalyzed Side Reactions with Molecular Oxygen may Contribute to Cell Signaling and Neurodegenerative Diseases
  63. Brain pyruvate and 2-oxoglutarate dehydrogenase complexes are mitochondrial targets of the CoA ester of the Refsum disease marker phytanic acid
  64. Inhibitors of the α-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons
  65. Phosphonate Analogues of α-Ketoglutarate Inhibit the Activity of the α-Ketoglutarate Dehydrogenase Complex Isolated from Brain and in Cultured Cells †
  66. The α-Ketoglutarate–Dehydrogenase Complex: A Mediator Between Mitochondria and Oxidative Stress in Neurodegeneration
  67. 2-Oxo acid dehydrogenase complexes in redox regulation. Role of the lipoate residues and thioredoxin
  68. 2-Oxo acid dehydrogenase complexes of multicellular organisms. Regulatory aspects
  69. Inactivation of the 2-oxo acid dehydrogenase complexes upon generation of intrinsic radical species
  70. Kinetic properties of the 2-oxoglutarate dehydrogenase complex from Azotobacter vinelandii
  71. Increased catalytic performance of the 2-oxoacid dehydrogenase complexes in the presence of thioredoxin, a thiol–disulfide oxidoreductase
  72. Structural Determinants for the Efficient and Specific Interaction of Thioredoxin with 2-Oxoacid Dehydrogenase Complexes
  73. Inhibition of select mitochondrial enzymes in PC12 cells exposed to S-(1,1,2,2-tetrafluoroethyl)-l-cysteine
  74. Subunit Interactions in the Mammalian  -Ketoglutarate Dehydrogenase Complex: EVIDENCE FOR DIRECT ASSOCIATION OF THE  -KETOGLUTARATE DEHYDROGENASE AND DIHYDROLIPOAMIDE DEHYDROGENASE COMPONENTS
  75. Homology Modelling of a Newly Discovered Thioredoxin Protein and Analysis of the Force Field and Electrostatic Properties
  76. Activation of Mitochondrial 2-Oxoacid Dehydrogenases by Thioredoxin
  77. Characterization of thioredoxins by sodium dodecyl sulfate-slab gel electrophoresis and high performance capillary electrophoresis
  78. Succinyl phosphonate inhibits α-ketoglutarate oxidative decarboxylation, catalyzed by α-ketoglutarate dehydrogenase complexes from E. coli and pigeon breast muscle
  79. Using lipoate enantiomers and thioredoxin to study the mechanism of the 2-oxoacid-dependent dihydrolipoate production by the 2-oxoacid dehydrogenase complexes
  80. Thioredoxin reduction dependent on α-ketoacid oxidation by α-ketoacid dehydrogenase complexes
  81. Inactivation of α-ketoglutarate dehydrogenase during oxidative decarboxylation of α-ketoadipic acid
  82. Effect of α-ketoglutarate and its structural analogues on hysteretic properties of α-ketoglutarate dehydrogenase
  83. Engineering of functional supramacromolecular complexes of proteins (enzymes) using reversed micelles as matrix microreactors
  84. Change in α-ketoglutarate dehydrogenase cooperative properties due to dihydrolipoate and NADH